Moreover, STAM mice with disruption of the insulin receptor in intestinal epithelial cells (ieIRKO mice) are shown to be resistant to insulin treatment in terms of preserving dysbiosis and suppressing the development of HCC. The gene discussed is INSR; the disease is hepatocellular carcinoma.